Clinical Trial Update: Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating mitomycin C combined with 5-fluorouracil and folinic acid in pretreated metastatic gastrointestinal cancers has completed enrollmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Gastrointestinal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Folinic acid (folinic acid)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Gastrointestinal Neoplasms, Neoplasm Metastasis | Phase 1, Phase 2 | Status: COMPLETED